Christoffer W. Tornøe

Author

United States Food and Drug Administration

Also Known As

C W Tornoe, C. W. Tornoe, C. W. Tornøe, Christoffer Tornoe, Christoffer W Tornøe, Christoffer W. Tornoe, Christoffer W. Tornøe, Christoffer Wenzel Tornøe

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Novo Nordisk (Denmark)Uppsala University Ferring Pharmaceuticals (Denmark)Technical University of Denmark

About

Christoffer W. Tornøe is an author at United States Food and Drug Administration specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	558
2	Engineering	2	2	160
3	Business	1	1	72
4	Health Sciences	1	1	13
5	Natural Sciences	1	1	74

Christoffer W. Tornøe

Publications

Citations

H-Index

Page 1

	Year	Citations
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun, New England Journal of Medicine	2023	2.1K
Population Pharmacokinetic and Concentration-QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies Jeffry Florian, Christoffer W. Tornøe, Richard C. Brundage, The Journal of Clinical Pharmacology Population PharmacokineticPharmacokinetic ModelingPharmacological StudyThorough Qt StudiesPharmacology	2011	168
Ethnic Differences in Insulin Sensitivity, β-Cell Function, and Hepatic Extraction Between Japanese and Caucasians: A Minimal Model Analysis Jonas Bech Møller, Chiara Dalla Man, Rune Viig Overgaard, The Journal of Clinical Endocrinology & Metabolism	2014	100
Non-Linear Mixed-Effects Models with Stochastic Differential Equations: Implementation of an Estimation Algorithm Rune Viig Overgaard, E. Niclas Jonsson, Christoffer W. Tornøe, Journal of Pharmacokinetics and Pharmacodynamics Nonlinear System IdentificationEngineeringEstimation AlgorithmStatistical ModelingNon-linear Mixed-effects Models	2005	86
Stochastic Differential Equations in NONMEM®: Implementation, Application, and Comparison with Ordinary Differential Equations Christoffer W. Tornøe, Rune Viig Overgaard, Henrik Agersø, Pharmaceutical Research EngineeringNatural SciencesStochastic SystemStochastic CalculusStochastic Dynamical System	2005	74
Creation of a Knowledge Management System for QT Analyses Christoffer W. Tornøe, Christine Garnett, Yaning Wang, The Journal of Clinical Pharmacology Heart FailurePharmacotherapyKnowledge TechnologyUs FoodTranslational Medicine	2010	72
Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations Christoffer W. Tornøe, Henrik Agersø, E. Niclas Jonsson, Computer Methods and Programs in Biomedicine MedicineBiostatisticsDifferential EquationsPharmacologyPharmacokinetics	2004	50
Pharmacometrics-Based Dose Selection of Levofloxacin as a Treatment for Postexposure Inhalational Anthrax in Children Fang Li, Partha Nandy, Shuchean Chien, Antimicrobial Agents and Chemotherapy Drug SafetyPostexposure Inhalational AnthraxSteady StateAntimicrobial StewardshipPharmacology	2009	40
Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic–pituitary–gonadal axis following treatment with GnRH analogues Christoffer W. Tornøe, Henrik Agersø, Thomas Senderovitz, British Journal of Clinical Pharmacology	2006	38
Reporting guidelines for population pharmacokinetic analyses Kevin Dykstra, Nitin Mehrotra, Christoffer W. Tornøe, Journal of Pharmacokinetics and Pharmacodynamics Drug SafetyPopulation PkTranslational MedicineTherapeutic Drug MonitoringPharmacokinetic Modeling	2015	36

Page 1